Wang L, Da H, Li X, Ran X, et al. Comparison of CD4/6 inhibitors, PI3K inhibitors, and mTOR inhibitors for patients with advanced HR+/HER2- Breast cancer: A network meta-analysis of 19 RCTs. Breast J 2020 Feb 9. doi: 10.1111/tbj.13780.
PMID: 32037589